The adoption of pets has been fueled by rising levels of urbanization and wealth, particularly in emerging nations, which has raised the demand for pet healthcare items including companion animal medications. The prevalence of many ailments, including allergies, decreased appetite, decreased energy, and behavioral anxiety, has also increased as a result of continued urbanization in the small Companion Animal Drugs Market. The demand for novel classes of pharmaceuticals, such as medications for companion animals, has been driven by this.
Animal health companies have been investing in cutting-edge diagnostic care in addition to conventional medications to help stop diseases before they start. As many important pharmaceuticals are no longer covered by intellectual property protection, businesses are also working to build generic capabilities to show bioequivalence to reference prescription drugs in the companion animal drug market.
Read More @ https://cmiinfonest.blogspot.com/2022/08/global-companion-animal-drugs-market.html
